Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-04-18 @ 2:48 AM
Study NCT ID:
NCT01246557
Status:
COMPLETED
Last Update Posted:
2014-04-04
First Post:
2010-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment
Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LENDEX-LLC-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Hospital Universitari Vall d'Hebron Research Institute.
Old Organization:
Investigator